Diabetes Patients Should Stay Away From Actos
Written by Faith Anderson on August 30, 2012
Potential Actos Side Effects Outweigh Benefits
Actos (pioglitazone) was initially introduced by Takeda Pharmaceuticals in July 1999, and was approved by the FDA for the treatment of type 2 diabetes in patients. Actos is a once-daily pill that functions by increasing the body’s sensitivity to insulin. Similar medications that also contain the same active ingredient as Actos include Duetact and ActoPlus Met. Concerns about the health risks associated with Actos have increased in recent years, particularly after use of the diabetes drug Avandia – which belongs to the same class of diabetes drugs as Actos – was heavily restricted in the United States amid concerns about serious heart risks. Shortly after, concerns about the link between Actos and bladder cancer surfaced.
In September 2010, the FDA issued a report saying the agency was investigating the potential for Actos to cause bladder cancer, after interim data from an ongoing study found an increased risk of bladder cancer side effects among Actos users. Last summer, an Actos study conducted in France also identified an increased incidence of bladder cancer among Actos patients, an alarming discovery that resulted in an Actos recall being issued in both France and Germany. In the United States, warnings about Actos side effects were increased by the FDA, indicating that use of the drug for longer than one year may increase the risk of bladder cancer, but the medication has yet to be recalled in the U.S.
Actos Lawsuits Filed for Bladder Cancer Side Effects
Actos maker Takeda Pharmaceuticals currently faces several hundreds product liability lawsuits filed on behalf of Actos users across the country who were diagnosed with bladder cancer after using the diabetes drug. The lawsuits allege that Takeda failed to provide adequate warnings about the side effect risks associated with long-term use of Actos, and many complaints claim that the current warnings on Actos drug labels remain insufficient. In addition to bladder cancer warnings, Actos also carries a black box warning – the strongest warning the FDA can place on prescription medications – notifying patients about the potential risk for congestive heart failure linked to Actos. If you have suffered a serious side effect and you believe Actos to be the cause, our consumer advocates can put you in touch with an experienced Actos attorney who can help. By filing a drug injury claim against Takeda Pharmaceuticals, you may be able to recover damages for your medical bills, pain and suffering, and more.